Your activity: 22 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Clinical risk factors for stroke, transient ischemic attack, and systemic embolism in the CHA2DS2-VASc score

Clinical risk factors for stroke, transient ischemic attack, and systemic embolism in the CHA2DS2-VASc score
(A) The risk factor-based approach expressed as a point based scoring system, with the acronym CHA2DS2-VASc
(NOTE: maximum score is 9 since age may contribute 0, 1, or 2 points)
CHA2DS2-VASc risk factor Points
Congestive heart failure

Signs/symptoms of heart failure or objective evidence of reduced left ventricular ejection fraction

+1
Hypertension

Resting blood pressure >140/90 mmHg on at least 2 occasions or current antihypertensive treatment

+1
Age 75 years or older +2
Diabetes mellitus

Fasting glucose >125 mg/dL (7 mmol/L) or treatment with oral hypoglycemic agent and/or insulin

+1
Previous stroke, transient ischemic attack, or thromboembolism +2
Vascular disease

Previous myocardial infarction, peripheral artery disease, or aortic plaque

+1
Age 65 to 74 years +1
Sex category (female) +1
 
(B) Adjusted stroke rate according to CHA2DS2-VASc score
CHA2DS2-VASc score Patients
(n = 73,538)
Stroke and thromboembolism event rate at 1-year follow-up (%)
0 6369 0.78
1 8203 2.01
2 12,771 3.71
3 17,371 5.92
4 13,887 9.27
5 8942 15.26
6 4244 19.74
7 1420 21.50
8 285 22.38
9 46 23.64
CHA2DS2-VASc: Congestive heart failure, Hypertension, Age (≥75; doubled), Diabetes, Stroke (doubled), Vascular disease, Age (65 to 74), Sex.
Part A from: Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18(11):1609-1678. By permission of Oxford University Press on behalf of the European Society of Cardiology. Copyright © 2016 Oxford University Press. Available at: www.escardio.org/.
Graphic 83272 Version 28.0